Amedeo Smart

Free Medical Literature Service


 

Amedeo

Migraine

  Free Subscription

26.02.2024

1 Cephalalgia
5 Headache
4 Lancet Neurol



    Cephalalgia

  1. VIANA M, Hougaard A, Tronvik E, Winnberg IG, et al
    Visual migraine aura iconography: A multicentre, cross-sectional study of individuals with migraine with aura.
    Cephalalgia. 2024;44:3331024241234809.
    >> Share


    Headache

  2. ROSSIGNOL J, Ouimet T, Poras H, Dallel R, et al
    Synergistic effect of combining dual enkephalinase inhibitor PL37 and sumatriptan in a preclinical model of migraine.
    Headache. 2024 Feb 22. doi: 10.1111/head.14681.
    >> Share

  3. LANGDON RL, DiSabella MT, Strelzik JA
    Screen time and pediatric headache: A scoping review of the literature.
    Headache. 2024;64:211-225.
    >> Share

  4. HAN C, Lim JY, Koike N, Kim SY, et al
    Regulation of headache response and transcriptomic network by the trigeminal ganglion clock.
    Headache. 2024;64:195-210.
    >> Share

  5. JICHA C, Pham K
    Neuromodulation for primary headache disorders: Advantages and challenges.
    Headache. 2024;64:226-228.
    >> Share

  6. PRADHAN SK, Gantenbein AR, Li Y, Shaban H, et al
    Daith piercing: Revisited from the perspective of auricular acupuncture systems. A narrative review.
    Headache. 2024;64:131-140.
    >> Share


    Lancet Neurol

  7. CHIANG CC, Porreca F, Robertson CE, Dodick DW, et al
    Potential treatment targets for migraine: emerging options and future prospects.
    Lancet Neurol. 2024;23:313-324.
    >> Share

  8. HAY DL
    A future treatment horizon for migraine?
    Lancet Neurol. 2024;23:226-227.
    >> Share

  9. TASSORELLI C, Nagy K, Pozo-Rosich P, Lanteri-Minet M, et al
    Safety and efficacy of atogepant for the preventive treatment of episodic migraine in adults for whom conventional oral preventive treatments have failed (ELEVATE): a randomised, placebo-controlled, phase 3b trial.
    Lancet Neurol. 2024 Feb 13:S1474-4422(24)00025.
    >> Share

  10. XU X, Dong L, Zhou J
    ELEVATEd hope for patients after migraine treatment failure.
    Lancet Neurol. 2024 Feb 13:S1474-4422(24)00072.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016